Adolescent substance abuse remains a significant problem in the United States, yet treatment centers do not always admit adolescent clients. In this paper, we first determine the extent to which treatment is available for adolescents in general and whether or not adolescent-specific (segregated) tracks are offered. Second, we examine the organizational characteristics associated with adolescent treatment. Third, we illuminate how the adolescent caseload in a treatment center is related to offering evidence-based practices (EBPs).
Methods
Drawing upon a nationally representative sample of US treatment programs, we use logistic regression to assess how organizational characteristics are associated with the provision of adolescent treatment. Using ordinal logistic regression, we analyze how the treatment center's adolescent caseload and organizational characteristics affect the extent to which a treatment center offers medication-assisted treatment (MAT) and psychosocial treatment.
Results
Half (49.5%) of treatment programs admitted adolescents, and 41.8% offered an adolescent-specific track. Findings from the logistic regression suggested several organizational characteristics that were significantly associated with treating adolescents and/or having an adolescent-only track. Our findings from the ordinal models indicated a negative relationship between the percent of adolescents in a treatment center and the extent of MAT, and a positive relationship between the percent of adolescent clients and the extent of psychosocial treatment offered.
Conclusions
This paper highlights organizational barriers to treatment entry for adolescents, who remain a small proportion of clients in treatment centers. When treatment centers serve adolescents, however, those adolescents are likely to receive care in adolescent-only tracks and/or services and in programs that offer several psychosocial EBPs. Finally, adolescents are less likely to receive treatment in centers that offer a variety of MAT.
FeinsteinEC, RichterL, FosterSE. Commentary: addressing the critical health problem of adolescent substance use through health care, research, and public policy. J Adolesc Health. 2012;50:431–436.
2.
National Center on Addiction Substance Abuse at Columbia University. Adolescent Substance Use: America's #1 Public Health Problem. New York: National Center on Addiction and Substance Abuse at Columbia University; 2011.
3.
Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2011 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2012.
4.
BaggioS, N'GoranAA, DelineS, . Patterns of cannabis use and prospective associations with health issues among young males. Addiction. 2014;109:937–945.
5.
McCambridgeJ, McAlaneyJ, RoweR. Adult consequences of late adolescent alcohol consumption: a systematic review of cohort studies. PLoS Med.2011;8:1–13.
6.
MarshallEJ. Adolescent alcohol use: risks and consequences. Alcohol Alcohol.2014;49:160–164.
7.
CarneyT, MyersB. Effectiveness of early interventions for substance-using adolescents: findings from a systematic review and meta-analysis. Subst Abuse Treat Prev Policy. 2012;7:1–15.
8.
DennisML, ScottCK, FunkRR, FossMA. The duration and correlates of addiction and treatment careers. J Subst Abuse Treat.2005;28:S51–S62.
9.
Substance Abuse and Mental Health Services Administration (SAMHSA). Results From the 2012 National Survey on Drug Use and Health: Summary of National Findings. Rockville, MD: Substance Abuse and Mental Health Services Administration; 2013.
10.
BattjesRJ, GordonMS, O'GradyKE, KinlockTW, CarswellMA. Factors that predict adolescent motivation for substance abuse treatment. J Subst Abuse Treat.2003;24:221–232.
11.
BroomeKM, JoeGW, SimpsonDD. Engagement models for adolescents in DATOS-A. J Adolesc Res.2001;16:608–623.
12.
MensingerJL, DiamondGS, KaminerY, WintersteenMB. Adolescent and Therapist perception of barriers to outpatient substance abuse treatment. Am J Addict.2006;15:16–25.
13.
Substance Abuse and Mental Health Services Administration (SAMHSA). The NSDUH Report: Substance Use Treatment Need Among Adolescents: 2003–2004. Rockville, MD: SAMHSA, Office of Applied Studies; 2006.
14.
GodleyMD, WhiteWL. A brief history and some current dimensions of adolescent treatment in the United States. Recent Dev Alcohol.2005;17:367–382.
15.
EtheridgeRM, SmithJC, Rounds-BryantJL, HubbardRL. Drug abuse treatment and comprehensive services for adolescents. J Adolesc Res.2001;16:563–589.
16.
FishmanMJ, WinstanleyEL, CurranE, GarrettS, SubramaniamG. Treatment of opioid dependence in adolescents and young adults with extended release naltrexone: preliminary case-series and feasibility. Addiction. 2010;105:1669–1676.
17.
Castellanos-RyanN, O'Leary-BarrettM, ConrodPJ. Substance-use in childhood and adolescence: a brief overview of developmental processes and their clinical implications. J Can Acad Child Adolesc Psychiatry. 2013;22:41–46.
18.
CallaghanRC, HathawayA, CunninghamJA, VetteseLC, WyattS, TaylorL. Does stage-of-change predict dropout in a culturally diverse sample of adolescents admitted to inpatient substance-abuse treatment? A test of the Transtheoretical Model. Addict Behav.2005;30:1834–1847.
19.
KaminerY.Adolescent Substance Abuse: A Comprehensive Guide to Theory and Practice. New York: Plenum Press; 1994.
20.
RidenourTA, CottlerLB, RobinsLN, ComptonWM, SpitznagelEL, Cunningham-WilliamsRM. Test of the plausibility of adolescent substance use playing a causal role in developing adulthood antisocial behavior. J Abnorm Psychol.2002;111:144–155.
21.
BranniganR, SchackmanBR, FalcoM, MillmanRB. The quality of highly regarded adolescent substance abuse treatment programs. Arch Pediatr Adolesc Med.2004;158:904–909.
22.
BrackenBK, RodolicoJ, HillKP. Sex, age, and progression of drug use in adolescents admitted for substance use disorder treatment in the northeastern United States: comparison with a national survey. Subst Abus.2013;34:263–272.
OlmsteadT, SindelarJL. To what extent are key services offered in treatment programs for special populations?J Subst Abuse Treat.2004;27:9–15.
25.
Substance Abuse and Mental Health Services Administration (SAMHSA). National Survey of Substance Abuse Treatment Services (N-SSATS): 2003. Data on Substance Abuse Treatment Facilities. Rockville, MD: SAMHSA; 2004.
26.
KnudsenHK. Adolescent-only substance abuse treatment: availability and adoption of components of quality. J Subst Abuse Treat.2009;36:195–204.
27.
HserYI, GrellaCE, HubbardRL, . An Evaluation of drug treatments for adolescents in 4 US cities. Arch Gen Psychiatry. 2001;58:689–695.
28.
Center for Substance Abuse Treatment. Treatment of Adolescents With Substance Abuse Disorders. Rockville, MD: SAMHSA; 1999. CSAT Treatment Improvement Protocol Series, No. 32. DHHS Publication No. SMA 99–3283.
29.
ChanY, DennisML, FunkRR. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J Subst Abuse Treat.2008;34:14–24.
30.
Esposito-SmythersC, WalshA, SpiritoA, RizzoC, GoldstonDB, KaminerY. Working with the suicidal client who also abuses substances. Cogn Behav Pract.2012;19:245–255.
KaminerY. Adolescent substance abuse treatment: evidence-based practice in outpatient services. Curr Psychiatry Rep.2002;4:397–401.
33.
The National Center on Addiction and Substance Abuse at Columbia University (CASA). Addiction Medicine: Closing the Gap Between Science and Practice. New York: CASA; 2012.
34.
FletcherAM.Inside Rehab.New York: Viking; 2013.
35.
RomanPM, BlumTC.Athens, GA: National Treatment Center Study University of Georgia; 1998.
36.
KellyJF, MyersMG. Adolescents’ participation in Alcoholics Anonymous and Narcotics Anonymous: review, implications and future directions. J Psychoactive Drugs.2007;39:259–269.
37.
WintersKC. Treating adolescents with substance use disorders: an overview of practice issues and treatment outcome. Subst Abus.1999;20:203–225.
38.
GalanterM, GlickmanL, SingerD. An overview of outpatient treatment of adolescent substance abuse. Subst Abus.2007;28:51–58.
39.
KellyJF, UrbanoskiK. Youth Recovery Contests: the incremental effects of 12-step attendance and involvement on adolescent outpatient outcomes. Alcohol Clin Exp Res.2012;36:1219–1229.
40.
Van GundyK. Substance Abuse in Rural and Small Town America: A Carsey Institute Report on Rural America. Durham, NH: Carsey Institute, University of New Hampshire; 2006.
41.
ZavelaKJ, BattistichV, GosselinkCA, DeanBJ. Say Yes First: follow up of a five-year rural drug prevention program. J Drug Educ.2004;34:73–88.
42.
YoungAM, GloverN, HavensJR. Rural adolescents’ nonmedical prescription drug use: implications for intervention. Prev Res.2012;19:7–9.
43.
PfefferJ, SalancikGR. The External Control of Organizations: A Resource Dependence Perspective. New York: Harper & Row; 1978.
44.
LuftH, RobinsonJC, GarnickD, MaerkiS, McPheeS. The role of specialized clinical services in competition among hospitals. Inquiry. 1986;23:83–94.
45.
RiggsPD. Treating adolescents for substance abuse and comorbid psychiatric disorders. Sci Pract Perspect. 2003;2:18–29.
46.
MarschLA, BickelWK, BadgerGJ, . Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial. Arch Gen Psychiatry. 2005;62:1157–1164.
47.
De SousaA, De SousaA. An open randomized trial comparing disulfiram and naltrexone in adolescents with alcohol dependence. J Subst Abuse.2008;13:382–388.
48.
NiederhoferH, StaffenW. Comparison of disulfiram and placebo in treatment of alcohol dependence of adolescents. Drug Alcohol Rev.2003;22:295–297.
49.
ClarkDB, WoodDS, CorneliusJR, BuksteinOG, MartinCS. Clinical practices in the pharmacological treatment of comorbid psychopathology in adolescents with alcohol use disorders. J Subst Abuse Treat.2003;25:293–295.
50.
DeasD. Evidence-based treatments for alcohol use disorders in adolescents. Pediatrics. 2008;121(Suppl 4):S348–S354.
51.
MatsonSC, HobsonG, Abdel-RasoulM, BonnyA. 5. Opiate abstinence among adolescents engaged in an outpatient buprenorphine clinic for the treatment of opiate dependence. J Adolesc Health.2013;52:S17.
52.
UpadhyayaH, DeasD. Pharmacological interventions for adolescent substance use disorders. In: KaminerY, BuksteinOG, eds. Adolescent Substance Abuse: Psychiatric Comorbidity and High-Risk Behaviors. New York: Routledge/Taylor & Francis Group; 2008:145–161.
53.
FiellinDA. Treatment of adolescent opioid dependence: no quick fix. JAMA. 2008;300:2057–2059.
54.
Drug Strategies. Treating Teens: A Guide to Adolescent Drug Programs. Washington, DC: Drug Strategies; 2002.
55.
DeasD, RiggsP, LangenbucherJ, GoldmanM, BrownS. Adolescents are not adults: developmental considerations in alcohol users. Alcohol Clin. Exp Res.2000;24:232–237.
56.
KaminerY, SlesnickN. Evidence-based cognitive-behavioral and family therapies for adolescent alcohol and other substance use disorders. Recent Dev Alcohol.2005;17:383–405.
57.
Mee-LeeDL, GartnerL, MillerMM, ShulmanGD, WilfordBB. Patient Placement Criteria for the Treatment of Substance Related Disorders. 2nd ed.Chevy Chase, MD: American Society of Addiction Medicine; 1996.
58.
LongJS, FreeseJ. Regression Models for Categorical Dependent Variables Using Stata. 2nd ed.College Station, TX: Stata Press; 2006.
59.
WoodE, SametJH, VolkowND. Physician education in addiction medicine. JAMA. 2013;310:1673–1674.
60.
KellyKJ, ComelloMLG, EdwardsRW. Attitudes of rural middle-school youth toward alcohol, tobacco, drugs, and violence. Rural Educ.2004;25:19–24.
61.
TaiB, StrausMM, LiuD, SparenborgS, JacksonR, McCartyD. The first decade of the national drug abuse treatment clinical trials network: bridging the gap between research and practice to improve drug abuse treatment. J Subst Abuse Treat.2010;38:S4–S13.
62.
McCartyD, GustafsonD, CapocciaVA, CotterF. Improving care for the treatment of alcohol and drug disorders. J Behav Health Serv Res.2009;36:52–60.
63.
AbrahamAJ, KnudsenHK, RomanPM. A longitudinal examination of alcohol pharmacotherapy adoption in substance use disorder treatment programs: patterns of sustainability and discontinuation. J Stud Alcohol Drugs.2011;72:669–677.
64.
KnudsenHK, AbrahamAJ, OserCB. Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure. Eval. Program Plann.2011;34:375–381.
65.
GordonAJ, KavanaghG, KrummM, . Facilitators and barriers in implementing buprenorphine in the Veterans Health Administration. Psychol Addict Behav.2011;25:215–224.
66.
OlivaEM, MaiselNC, GordonAJ, HarrisAH. Barriers to use of pharmacotherapy for addiction disorders and how to overcome them. Curr Psychiatry Rep.2011;13:374–381.
67.
ComptonWM, SteinJB, RobertsonEB, PintelloD, PringleB, VolkowND. Charting a course for health services research at the National Institute on Drug Abuse. J Subst Abuse Treat.2005;29:167–172.
68.
CarrollKM. Dissemination of evidence-based practices: how far we've come, and how much further we've got to go. Addiction. 2012;107:1031–1033.
69.
BradleyKA, KivlahanDR. Bringing patient-centered care to patients with alcohol use disorders. JAMA.2014;311:1861–1862.
